Abstract
Ischemic preconditioning (IPC) is an evolutionarily conserved endogenous mechanism whereby short periods of non-lethal exposure to hypoxia alleviate damage caused by subsequent ischemia reperfusion (IR). Pharmacologic targeting has suggested that the mitochondrial ATP-sensitive potassium channel (mKATP) is central to IPC signaling, despite its lack of molecular identity. Here, we report that isolated Caenorhabditis elegans mitochondria have a mKATP channel with the same physiologic and pharmacologic characteristics as the vertebrate channel. Since C. elegans also exhibit IPC, our observations provide a framework to study the role of mKATP in IR injury in a genetic model organism.
Keywords: ATP sensitive potassium channel, mKATP, preconditioning, ischemia, mitochondria, C. elegans
Introduction
Mitochondria are essential for cellular function and are a sensitive target for damage induced by ischemia reperfusion (IR) injury, such as the overproduction of reactive oxygen species (ROS) and overload of Ca2+, both of which can trigger the formation of the mitochondrial permeability transition (PT) pore at reperfusion [1–3]. Mitochondrial dysfunction has significant implications for post-ischemic recovery [4; 5]. Despite being the site of such pathological events, mitochondria are also involved in the protective mechanism of ischemic preconditioning (IPC) whereby short non-lethal periods of ischemia protect the heart from subsequent prolonged ischemic insults [6]. IPC triggers an array of cell signaling pathways, many of which converge at the mitochondrion. Recent work has suggested that a primary target of IPC signaling is the mitochondrial ATP sensitive K+ channel (mKATP) [7; 8], and that this channel is essential for the mechanism of cardioprotection recruited by IPC.
The mKATP was first described electro-physiologically [9], then subsequently via its pharmacological sensitivity, both of which demonstrate similarities to plasma membrane and sarcoplasmic reticulum ATP sensitive K+ channels or “surface” KATP channels. For example, the sulfonylurea diazoxide’s cardioprotective activity was originally thought to be due to triggering of surface KATP channels, but its protective effects were later shown to relate specifically to mKATP channel opening [10]. Moreover, the protective effects of IPC can be mimicked by mKATP channel activators [11–13] and prevented by channel inhibitors [14; 15]. The protection mediated through the opening of the mKATP is thought to involve membrane depolarization through K+ influx [16], which may translate to decreased Ca2+ uptake and ROS generation [17]. Additionally, K+ entry obligates the influx of anions and water, thereby augmenting matrix volume [18] and potentially improving energy metabolism and interfering with PT pore assembly [16; 19]. Despite the central role of the mKATP in IPC and the well-documented molecular characterization of the surface KATP channels, none of the sequences or splice variants of the inward rectifying K+ channel (Kir) or sulfonylurea receptor (SUR) genes that comprise surface KATP channels [20] contain mitochondrial targeting sequences, and it is unclear whether the mKATP channel is derived from surface KATP channels [21–23] or is a unique protein entity [24].
Efforts centered on mammalian model systems have yielded no definitive answer regarding the molecular identity of the mKATP channels. One example of the problems faced by this field is the recent discovery that many of the antibodies used to identify SUR and Kir subunits in purified mitochondria can recognize off-target proteins unrelated to K+ channel function [25]. Furthermore, knockout mice for Kir and SUR genes have been generated and are viable, but the ability to test these mice in IPC experiments is confounded by the obligatory effects of knocking out surface KATP channel function on various cardiovascular functions. A key example is the SUR2−/− mouse which exhibits elevated blood glucose, a known risk factor for increased IR injury [26]. These limitations may be further compounded by potential nonspecific effects of pharmacological agents used in assaying the mKATP channel [27–29].
One potential solution to these limitations is to employ a model organism. In this regard, IPC in the nematode worm C. elegans results in protection from ischemic death similar to “late” preconditioning seen in mammals [30; 31]. To begin testing the hypothesis that IPC in worms occurs through an evolutionarily conserved mechanism involving mKATP, we assayed mKATP activity in purified mitochondria using a K+ swelling assay [32–35]. Our results demonstrate mKATP channel activity that both pharmacologically and physiologically mimics its mammalian counterpart. The presence of the channel in this model organism provides several advantages in determining its molecular identity. The reduced cellular complexity of worms and absence of vasculature may reduce confounding systemic effects, while the use of genetics to eliminate candidate channel expression should eliminate off-target pharmacologic effects. Future determination of the identity of the mKATP channel in worms will represent a significant advance in the field of IR injury and protection by IPC.
Materials and Methods
All chemicals and reagents were from Sigma (St Louis MO) unless otherwise stated. Culture and growth of C. elegans N2 strain was performed essentially as described [36]. 2 × 105 embryos or starved L1 worms were plated onto 2 × 150 mm plates, each seeded with 6 ml of HB101 bacteria (~50% slurry), condensed from a 500 ml culture of Terrific Broth. Plates were incubated in a humidified atmosphere at 20°C for 3–4 days, resulting in staged adult worms ready for mitochondrial isolation.
Mitochondria were isolated from adult C. elegans by a method based on that described in [37]. Worms from 2 plates were transferred at 25°C into 50 ml of M9 media (22 mM KH2PO4, 42 mM Na2HPO4, 86 mM NaCl, 1 mM MgSO4, pH 7) in a conical tube, then incubated for 20 min. on ice resulting in precipitation / settling. Supernatant (45 ml) was removed, and the worm pellet rinsed twice with 45 ml ice-cold M9 and once with 45 ml ice-cold mitochondrial isolation medium (IM: 220 mM mannitol, 70 mM sucrose, 5 mM MOPS, 2 mM EGTA, pH 7.4, filtered) containing 0.4% BSA. Worms were settled by gravity for 10 min. between rinses, and finally by centrifugation for 1 min. at 1000 × g, and suspension of the final pellet in ~1.5 ml of IM. Worms were transferred using a cut-off pipet tip to a mortar on-ice containing 2g of washed sand per ml of worms, followed by grinding with a pestle for 1 min. Ground worms were extracted from the sand using 3 × 3 ml aliquots of IM, transferring to a 10 ml conical tube. Following 3 additional settling/wash steps in IM+BSA to remove excess sand, the worm suspension was then homogenized with a glass Dounce homogenizer in IM+BSA. The homogenate was diluted and centrifuged at 600 × g for 5 min. The supernatant was then filtered through 300 µm mesh and centrifuged at 7000 × g for 10 min. The pellet was resuspended in 1.5 ml IM, and centrifuged at 7000 × g for 5 min. Another wash/centrifugation step was performed, and the final mitochondrial pellet suspended in 150 µl IM and stored on ice until use (within 2 hrs). Protein was determined by the Folin-Phenol method [38], against a standard curve constructed with BSA. Two plates of worms typically yielded ~6 mg mitochondrial protein.
Immediately following isolation, mitochondrial viability was determined by the measuring respiratory function (O2 consumption) using a Clark-type O2 electrode in a stirred chamber at 25°C. Mitochondria (0.25 mg protein) were suspended in 0.25 ml respiration buffer (RB: 195 mM mannitol, 25 mM sucrose, 40 mM HEPES, 0.25% w/v fat-free BSA, pH 7.35 at 25°C). Addition of substrates (10 mM pyruvate plus 5 mM malate, or 5mM succinate) was used to initiate state 2, followed by the addition of ADP (200 µM) to initiate state 3 respiration. Oligomycin (1 µg/ml) was then added to enforce state 4 respiration.
mKATP channel activity was measured by the commonly used swelling/light-scatter assay [32–35] at 520 nm using a Beckman DU800 spectrophotometer. Mitochondria (0.25 mg/ml) were rapidly added to a stirred cuvette containing mKATP buffer (100 mM KCl, 10 mM HEPES, 2 mM succinate, 2 mM MgCl2, 2 mM KH2PO4, 1 µg/ml oligomycin, pH 7.2 at 37°C). In some experiments, as indicated by figure legends, K+ in the buffer was replaced with Na+. All differences between experimental groups were determined using ANOVA; p<0.05 was considered significant.
Results
We and others have previously noted that the mKATP channel activity degrades rapidly in mammalian mitochondria [32; 33], thus contraindicating the use of proteases to break the C. elegans cuticle. Instead, a 2-step homogenization protocol was developed in which whole worms were first ground with sand in a pestle and mortar, followed by several passes in a glass Dounce homogenizer. This was followed by several centrifugation steps, resulting in a mitochondrial fraction. The respiratory properties of these isolated mitochondria are shown in Fig. 1., indicating that the mitochondria were moderately well coupled. Respiratory control ratio (RCR) values were not as high as those typically seen in mammalian mitochondria, however worms are poikilotherms and prolonged incubation at 37°C is lethal. Correspondingly, a lower incubation temperature was used in the respiration reactions (25°C vs. 37°C for mammalian mitochondria [33]), which slows down state 3 respiration considerably, and this may partly account for the lower RCR.
Figure 1. O2 consumption by isolated C. elegans mitochondria.
Mitochondria were isolated as described and suspended at a concentration of 1 mg protein/ml in respiration buffer containing 2.5 mg/ml of BSA. O2 consumption was measured using a Clark-type O2 electrode in a thermostatic chamber at 25°C. (A) Representative respiration traces: Following the addition of mitochondria, Left trace: 10 mM Pyruvate plus 5 mM Malate (Pyr+Mal) were added to induce state 2 respiration, 200 µM ADP to induce state 3, and 1 µg/ml oligomycin (Oligo) to induce state 4. Right trace: 10 mM Succinate (Succ) was added followed by 200 µM ADP. (B) Quantitation of the respiratory control ratio (state 3 divided by state 4) from several experiments as shown in A. Data are means ± SEM, N>8.
The rapid osmotic swelling of mitochondria in K+ based media, which results in a decrease in light scattering that is assayed spectrophotometrically, has been widely used to assay mKATP channel function [32–35]. As shown in Fig. 2a, we were able to recapitulate mKATP mediated osmotic swelling of C. elegans mitochondria, and this activity persisted for up to 3 hrs. following mitochondrial isolation. In Fig. 2b we demonstrated that the channel exhibits the classical mKATP pharmacologic profile as previously reported in the literature and in this laboratory [10; 15; 17; 33; 39], i.e. swelling under baseline conditions in K+ based media (open channel), inhibition by ATP, re-activation by diazoxide superseding the effect of ATP, and inhibition again by 5-HD over-riding the effect of diazoxide plus ATP. No effect of these agents on swelling was observed in Na+ based media [33], and mitochondria isolated from adult worms staged either as embryos or as starved L1 larvae behaved similarly (data not shown).
Figure 2. The C. elegans mKATP channel.
(A): Osmotic swelling assay for determination of the mKATP channel activity. Representative swelling trace of mitochondria (~0.25 mg/ml) in K+ media. Where indicated, 1 mM ATP, 10 µM diazoxide (DZX, a KATP opener), or 300 µM 5-hydroxydecanoate (5-HD, a KATP antagonist) were present in the media. (B): Magnitude of swelling, relative to the control, as determined by a decrease in A520 after 0.2 min. incubation in K+ media (filled bars) or in Na+ media (open bars). (C): The pharmacological profile of the C. elegans mKATP channel demonstrated in response to activators and inhibitors in K+ media. Chromakalim (Crmk), pinacidil (Pncd) and malonate (Malo) are all KATP openers, while 5-HD and glyburide (Gly) are KATP antagonists. The 3 conditions for each opener (i.e. opener alone and with 2 antagonists) are shaded the same. Control swelling after 0.2 min resulted in a decrease in A520 of 0.0233 ± 0.0013 OD units in K+ media and 0.0167 ± 0.004 OD units in Na+ media. Experimental conditions are listed below the x-axis. Data are means ± SEM *p<0.05 vs. control, **p<0.05 vs. ATP, ***p<0.05 vs. ATP+channel activator; N≥4.
Fig. 2C shows that the C. elegans mKATP channel also responds to a variety of other reagents in exactly the same manner as previously observed for the mammalian mitochondrial channel [10; 15; 17; 33; 39]. The mKATP channel openers cromakalim, pinacidil and malonate all reversed the inhibition of swelling by ATP, and the mKATP channel antagonists 5-HD and glyburide both reversed the effects of cromakalim, pinacidil and malonate.
Discussion
Our results demonstrate that viable mitochondria isolated from C. elegans contain a mKATP channel identical to the mammalian mKATP channel in every aspect so far examined. This fundamental observation is the first report on the existence of a mKATP channel in multicellular invertebrates, suggesting that channel activity is evolutionarily conserved. Given the ability of C. elegans to undergo IPC [30], we further suggest that the mKATP channel is likely a fundamental component of all evolutionarily conserved preconditioning signal pathways.
Another advantage to the C. elegans model system in regard to mKATP channel function, is the discovery herein that the channel activity was stable in isolated mitochondria for up to 3 hours. The mKATP channel swelling assay has been criticized recently due to its poor reproducibility by some laboratories [40], and as discussed above a key factor governing the ability to assay the channel by this method is the freshness of isolated mitochondria [32; 33]. The issue of channel stability may account for several related discrepancies in the mKATP channel literature, and thus the greater stability of the C. elegans mKATP channel activity may permit greater consensus in the future studies on this channel.
Numerous studies have centered on unraveling the molecular mechanisms of IPC over the past two decades. Despite significant advances, the molecular identity of mKATP is unknown, and this impairs progress in developing therapeutics to protect the heart and other organs from IR injury, a major cause of morbidity and mortality worldwide[41]. In addition it is known that IPC is less effective in certain patient cohorts (e.g. diabetics) [42], but the mechanisms underlying this are unclear. It is possible that differences in mitochondrial K+ channel activity may underlie such effects, and thus identification of these channels will permit enhanced diagnosis and treatment of individuals refractory to IPC.
Despite surface KATP channels being well characterized at the molecular level (i.e. with well defined genes and protein structures, see [20] for review), none of the known Kir or SUR genes or their splice variants have mitochondrial targeting sequences. In addition, several antibodies used to identify SUR and Kir subunits in purified mitochondria are now known to recognize off-target unrelated proteins [25]. Thus, a competing hypothesis has emerged, that the mKATP channel may not be comprised of classical Kir/SUR proteins [21–23], and instead is comprised of other mitochondrial proteins [24]. Candidates for mKATP that have been proposed include: succinate dehydrogenase (complex II), the phosphate carrier, mitochondrial ATP-binding cassette protein-1 (mABC-1), adenine nucleotide translocator, and ATP synthase [24]. The conservation of function and direct genetic orthologies between mammalian and worm counterparts makes C. elegans an attractive model to test whether these molecules are components of or perhaps regulate mKATP. Our demonstration that worms possess an mKATP channel activity is fundamental to this process, and the future analysis of candidate mutants should allow unambiguous insight into the identity of the mKATP channel.
Furthermore, it has recently been discovered that, analogous to mammals, C. elegans can also be protected from ischemic / hypoxic injury by preconditioning with volatile anesthetics (so-called “anesthetic preconditioning”, APC) [31]. In addition, emerging work suggests that Ca2+ activated K+ channels in the mitochondrion (mKCa) may participate in APC signaling, possibly playing a similar mechanistic role to mKATP channels. Thus, it is possible that the application of mitochondrial isolation methods and channel activity assays outlined herein, could also be applied to the molecular identification of the mKCa channel and its regulators.
Acknowledgements
We thank Phil Morgan and Marge Sedensky (Seattle Children’s Hospital) for an introduction to preparing C. elegans mitochondria. This work was supported in part by PHS grants R01 HL080810 (to KN) and RO1 HL071158 (to PSB). APW is the recipient of an American Heart Association Founders Affiliate pre-doctoral fellowship award.
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
Reference List
- 1.Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am.J.Physiol Cell Physiol. 2004;287:C817–C833. doi: 10.1152/ajpcell.00139.2004. [DOI] [PubMed] [Google Scholar]
- 2.Kim JS, Jin Y, Lemasters JJ. Reactive oxygen species, but not Ca2+ overloading, trigger pH- and mitochondrial permeability transition-dependent death of adult rat myocytes after ischemia-reperfusion. Am.J.Physiol Heart Circ.Physiol. 2006;290:H2024–H2034. doi: 10.1152/ajpheart.00683.2005. [DOI] [PubMed] [Google Scholar]
- 3.Griffiths EJ, Halestrap AP. Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem.J. 1995;307(Pt 1):93–98. doi: 10.1042/bj3070093. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Akar FG, Aon MA, Tomaselli GF, O'Rourke B. The mitochondrial origin of postischemic arrhythmias. J.Clin.Invest. 2005;115:3527–3535. doi: 10.1172/JCI25371. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Lesnefsky EJ, Moghaddas S, Tandler B, Kerner J, Hoppel CL. Mitochondrial dysfunction in cardiac disease: ischemia--reperfusion, aging, and heart failure. J.Mol.Cell Cardiol. 2001;33:1065–1089. doi: 10.1006/jmcc.2001.1378. [DOI] [PubMed] [Google Scholar]
- 6.Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124–1136. doi: 10.1161/01.cir.74.5.1124. [DOI] [PubMed] [Google Scholar]
- 7.Facundo HT, Fornazari M, Kowaltowski AJ. Tissue protection mediated by mitochondrial K+ channels. Biochim.Biophys.Acta. 2006;1762:202–212. doi: 10.1016/j.bbadis.2005.06.003. [DOI] [PubMed] [Google Scholar]
- 8.Garlid KD, Dos SP, Xie ZJ, Costa AD, Paucek P. Mitochondrial potassium transport: the role of the mitochondrial ATP-sensitive K(+) channel in cardiac function and cardioprotection. Biochim.Biophys.Acta. 2003;1606:1–21. doi: 10.1016/s0005-2728(03)00109-9. [DOI] [PubMed] [Google Scholar]
- 9.Inoue I, Nagase H, Kishi K, Higuti T. ATP-sensitive K+ channel in the mitochondrial inner membrane. Nature. 1991;352:244–247. doi: 10.1038/352244a0. [DOI] [PubMed] [Google Scholar]
- 10.Garlid KD, Paucek P, Yarov-Yarovoy V, Murray HN, Darbenzio RB, Dx00027;Alonzo AJ, Lodge NJ, Smith MA, Grover GJ. Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection. Circ.Res. 1997;81:1072–1082. doi: 10.1161/01.res.81.6.1072. [DOI] [PubMed] [Google Scholar]
- 11.Armstrong SC, Liu GS, Downey JM, Ganote CE. Potassium channels and preconditioning of isolated rabbit cardiomyocytes: effects of glyburide and pinacidil. J.Mol.Cell Cardiol. 1995;27:1765–1774. doi: 10.1016/s0022-2828(95)90986-9. [DOI] [PubMed] [Google Scholar]
- 12.Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ.Res. 1992;70:223–233. doi: 10.1161/01.res.70.2.223. [DOI] [PubMed] [Google Scholar]
- 13.Mizumura T, Nithipatikom K, Gross GJ. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs. Circulation. 1995;92:1236–1245. doi: 10.1161/01.cir.92.5.1236. [DOI] [PubMed] [Google Scholar]
- 14.Auchampach JA, Grover GJ, Gross GJ. Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate. Cardiovasc.Res. 1992;26:1054–1062. doi: 10.1093/cvr/26.11.1054. [DOI] [PubMed] [Google Scholar]
- 15.Jaburek M, Yarov-Yarovoy V, Paucek P, Garlid KD. State-dependent inhibition of the mitochondrial KATP channel by glyburide and 5-hydroxydecanoate. J.Biol.Chem. 1998;273:13578–13582. [PubMed] [Google Scholar]
- 16.da Silva MM, Sartori A, Belisle E, Kowaltowski AJ. Ischemic preconditioning inhibits mitochondrial respiration, increases H2O2 release, and enhances K+ transport. Am.J.Physiol Heart Circ.Physiol. 2003;285:H154–H162. doi: 10.1152/ajpheart.00955.2002. [DOI] [PubMed] [Google Scholar]
- 17.Kowaltowski AJ, Seetharaman S, Paucek P, Garlid KD. Bioenergetic consequences of opening the ATP-sensitive K(+) channel of heart mitochondria. Am.J.Physiol Heart Circ.Physiol. 2001;280:H649–H657. doi: 10.1152/ajpheart.2001.280.2.H649. [DOI] [PubMed] [Google Scholar]
- 18.Eliseev RA, Vanwinkle B, Rosier RN, Gunter TE. Diazoxide-mediated preconditioning against apoptosis involves activation of cAMP-response element-binding protein (CREB) and NFkappaB. J.Biol.Chem. 2004;279:46748–46754. doi: 10.1074/jbc.M406217200. [DOI] [PubMed] [Google Scholar]
- 19.Costa AD, Quinlan CL, Andrukhiv A, West IC, Jaburek M, Garlid KD. The direct physiological effects of mitoK(ATP) opening on heart mitochondria. Am.J.Physiol Heart Circ.Physiol. 2006;290:H406–H415. doi: 10.1152/ajpheart.00794.2005. [DOI] [PubMed] [Google Scholar]
- 20.Zingman LV, Alekseev AE, Hodgson-Zingman DM, Terzic A. ATP-sensitive potassium channels: metabolic sensing and cardioprotection. J.Appl.Physiol. 2007;103:1888–1893. doi: 10.1152/japplphysiol.00747.2007. [DOI] [PubMed] [Google Scholar]
- 21.Mironova GD, Negoda AE, Marinov BS, Paucek P, Costa AD, Grigoriev SM, Skarga YY, Garlid KD. Functional distinctions between the mitochondrial ATP-dependent K+ channel (mitoKATP) and its inward rectifier subunit (mitoKIR) J.Biol.Chem. 2004;279:32562–32568. doi: 10.1074/jbc.M401115200. [DOI] [PubMed] [Google Scholar]
- 22.Paucek P, Mironova G, Mahdi F, Beavis AD, Woldegiorgis G, Garlid KD. Reconstitution and partial purification of the glibenclamide-sensitive, ATP-dependent K+ channel from rat liver and beef heart mitochondria. J.Biol.Chem. 1992;267:26062–26069. [PubMed] [Google Scholar]
- 23.Bajgar R, Seetharaman S, Kowaltowski AJ, Garlid KD, Paucek P. Identification and properties of a novel intracellular (mitochondrial) ATP-sensitive potassium channel in brain. J.Biol.Chem. 2001;276:33369–33374. doi: 10.1074/jbc.M103320200. [DOI] [PubMed] [Google Scholar]
- 24.Ardehali H, Chen Z, Ko Y, Mejia-Alvarez R, Marban E. Multiprotein complex containing succinate dehydrogenase confers mitochondrial ATP-sensitive K+ channel activity. Proc.Natl.Acad.Sci.U.S.A. 2004;101:11880–11885. doi: 10.1073/pnas.0401703101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Brian FD, Rucker JJ, Marban E. Is Kir6.1 a subunit of mitoK(ATP)? Biochem.Biophys.Res.Commun. 2008;366:649–656. doi: 10.1016/j.bbrc.2007.11.154. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Chutkow WA, Samuel V, Hansen PA, Pu J, Valdivia CR, Makielski JC, Burant CF. Disruption of Sur2-containing K(ATP) channels enhances insulin-stimulated glucose uptake in skeletal muscle. Proc.Natl.Acad.Sci.U.S.A. 2001;98:11760–11764. doi: 10.1073/pnas.201390398. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Dzeja PP, Bast P, Ozcan C, Valverde A, Holmuhamedov EL, Van Wylen DG, Terzic A. Targeting nucleotide-requiring enzymes: implications for diazoxide-induced cardioprotection. Am.J.Physiol Heart Circ.Physiol. 2003;284:H1048–H1056. doi: 10.1152/ajpheart.00847.2002. [DOI] [PubMed] [Google Scholar]
- 28.Schafer G, Wegener C, Portenhauser R, Bojanovski D. Diazoxide, an inhibitor of succinate oxidation. Biochem.Pharmacol. 1969;18:2678–2681. [PubMed] [Google Scholar]
- 29.Hanley PJ, Gopalan KV, Lareau RA, Srivastava DK, von MM, Daut J. Beta-oxidation of 5-hydroxydecanoate, a putative blocker of mitochondrial ATP-sensitive potassium channels. J.Physiol. 2003;547:387–393. doi: 10.1113/jphysiol.2002.037044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Dasgupta N, Patel AM, Scott BA, Crowder CM. Hypoxic preconditioning requires the apoptosis protein CED-4 in C. elegans. Curr.Biol. 2007;17:1954–1959. doi: 10.1016/j.cub.2007.10.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Jia B, Crowder CM. Volatile anesthetic preconditioning present in the invertebrate Caenorhabditis elegans. Anesthesiology. 2008;108:426–433. doi: 10.1097/ALN.0b013e318164d013. [DOI] [PubMed] [Google Scholar]
- 32.Facundo HT, de Paula JG, Kowaltowski AJ. Mitochondrial ATP-sensitive K+ channels are redox-sensitive pathways that control reactive oxygen species production Free. Radic.Biol.Med. 2007;42:1039–1048. doi: 10.1016/j.freeradbiomed.2007.01.001. [DOI] [PubMed] [Google Scholar]
- 33.Wojtovich AP, Brookes PS. The endogenous mitochondrial complex II inhibitor malonate regulates mitochondrial ATP-sensitive potassium channels: Implications for ischemic preconditioning. Biochim.Biophys.Acta. 2008;1777:882–889. doi: 10.1016/j.bbabio.2008.03.025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Beavis AD, Brannan RD, Garlid KD. Swelling and contraction of the mitochondrial matrix. I. A structural interpretation of the relationship between light scattering and matrix volume. J.Biol.Chem. 1985;260:13424–13433. [PubMed] [Google Scholar]
- 35.Garlid KD, Beavis AD. Swelling and contraction of the mitochondrial matrix. II. Quantitative application of the light scattering technique to solute transport across the inner membrane. J.Biol.Chem. 1985;260:13434–13441. [PubMed] [Google Scholar]
- 36.Brenner S. The genetics of Caenorhabditis elegans. Genetics. 1974;77:71–94. doi: 10.1093/genetics/77.1.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Kayser EB, Morgan PG, Hoppel CL, Sedensky MM. Mitochondrial expression and function of GAS-1 in Caenorhabditis elegans. J.Biol.Chem. 2001;276:20551–20558. doi: 10.1074/jbc.M011066200. [DOI] [PubMed] [Google Scholar]
- 38.Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J.Biol.Chem. 1951;193:265–275. [PubMed] [Google Scholar]
- 39.Garlid KD, Paucek P. Mitochondrial potassium transport: the K(+) cycle. Biochim.Biophys.Acta. 2003;1606:23–41. doi: 10.1016/s0005-2728(03)00108-7. [DOI] [PubMed] [Google Scholar]
- 40.Das M, Parker JE, Halestrap AP. Matrix volume measurements challenge the existence of diazoxide/glibencamide-sensitive KATP channels in rat mitochondria. J.Physiol. 2003;547:893–902. doi: 10.1113/jphysiol.2002.035006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng ZJ, Flegal K, O'Donnell C, Kittner S, Lloyd-Jones D, Goff DC, Jr, Hong Y, Adams R, Friday G, Furie K, Gorelick P, Kissela B, Marler J, Meigs J, Roger V, Sidney S, Sorlie P, Steinberger J, Wasserthiel-Smoller S, Wilson M, Wolf P. Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006;113:e85–e151. doi: 10.1161/CIRCULATIONAHA.105.171600. [DOI] [PubMed] [Google Scholar]
- 42.Kersten JR, Toller WG, Gross ER, Pagel PS, Warltier DC. Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality. Am.J.Physiol Heart Circ.Physiol. 2000;278:H1218–H1224. doi: 10.1152/ajpheart.2000.278.4.H1218. [DOI] [PubMed] [Google Scholar]